[Therapeutic experiences with a slow-release preparation of L-dopa (Madopar "HBS") in patients with advanced Parkinson disease].
Poewe
W
W
Universitätsklinik für Neurologie, Innsbruck.
Kleedorfer
B
B
Gerstenbrand
F
F
D000368:Aged; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D007980:Levodopa
Therapeutische Erfahrungen mit einem "slow-release" Präparat von L-Dopa (Madopar "HBS") bei Patienten mit fortgeschrittener Parkinson-Krankheit.